Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV real-world multicenter prospective cohort study of 小儿荆杏止咳颗粒 in children with acute bronchitis or post-infectious cough
CTR20241894Phase 4Active
- Sponsor
- Fangsheng Pharmaceutical
- Start
- Jul 2024
- Countries
- 1
01
Overview
A Phase 4 trial of xiaoer jingxing zhike in acute bronchitis, postinfectious cough, sponsored by Fangsheng Pharmaceutical. Started Jul 2024; status: active.
02
Drugs
xiaoer jingxing zhike
03
Conditions
acute bronchitispostinfectious cough
Beyond the preview
Go deeper on CTR20241894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241894.